Search Results 81-90 of 17698 for Pancreatic cancer
Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180° of vessel wall circumference, and/or reconstructible occlusion of the SMV-PV.
Researchers found that the GSK-3 inhibitor significantly increased pancreatic tumor cancer cell death and prolonged survival in tumor-bearing models when ...
Pancreatic cancer and chronic pancreatitis both produce the same signs of disease in the pancreas, such as inflammation, but cancer in the organ is a life ...
CA 19-9 tumor marker test especially important for early-stage patients, Mayo finds. NAPA, Calif. — Only 1 in 5 U.S. pancreatic cancer patients receive a ...
Historically, most patients with pancreatic cancer whose tumors grow outside the pancreas to encompass veins and arteries have been told the cancer is ...
... pancreatic cancer (PDAC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
When she was 38, Radhika Sattanathan received a frightening diagnosis of pancreatic cancer. Taking the advice of her physician in India, Radhika sought care ...
Pancreatic cancer remains the fourth leading cause of cancer-associated deaths in the United States. While prognosis has improved for other major cancers ...
Diabetes can develop when chronic pancreatitis damages cells that produce insulin. Pancreatic cancer. Long-standing inflammation in the pancreas is a risk ...
— In an academic-industrial collaboration, Mayo Clinic is assessing in a clinical trial a new radiotracer in pancreatic cancer imaging. As part of the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.